Physician profile
Abhijeet Basoor
NPI 1194993147
$2,966.29
in general payments reported to CMS, 2019-2025
32 companies · $397 in 2025
The $397 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $796 · 2020: $187 · 2021: $27.93 · 2022: $411 · 2023: $727 · 2024: $422 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,545.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $433.09 | 2019-2024 | |
| Pfizer INC. | $359.96 | 2019-2024 | |
| Boston Scientific Corporation | $352.79 | 2019-2024 | Ranger, Avvigo Guidance System, Wolverine Coronary Cutting Balloon |
| Abiomed | $287.13 | 2024-2025 | Impella |
| Medtronic, INC. | $171.47 | 2023-2025 | Symplicity G3, Abre |
| Abbott Laboratories | $148.43 | 2019-2023 | Aveir |
| Janssen Pharmaceuticals, INC | $136.11 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $131.36 | 2022-2024 | Verquvo |
| Amgen INC. | $117.40 | 2019-2024 | Repatha |
| Itamar Medical INC | $87.48 | 2022-2023 | Watchpatone |
| Inari Medical, INC. | $70.86 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sanofi-Aventis U.S. LLC | $63.95 | 2019-2021 | |
| Edwards Lifesciences Corporation | $59.97 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.04 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $56.15 | 2022-2023 | Brilinta |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $55.04 | 2022-2023 | Camzyos |
| United Therapeutics Corporation | $47.04 | 2019-2024 | Tyvaso |
| Novo Nordisk INC | $37.82 | 2024 | Wegovy |
| Actelion Pharmaceuticals US, INC. | $32.97 | 2023-2024 | Opsumit, Uptravi |
| Angiodynamics, INC. | $32.53 | 2022-2023 | Auryon Laser System 100-120 Vac |
| Baxter Healthcare | $32.34 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Kiniksa Pharmaceuticals, LTD. | $27.77 | 2023 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $24.33 | 2019 | |
| Gilead Sciences, INC. | $21.79 | 2019 | |
| Janssen Scientific Affairs, LLC | $21.40 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $18.95 | 2024 | Arcalyst |
| Philips North America LLC | $17.91 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $17.83 | 2024 | |
| Tactile Systems Technology INC | $14.24 | 2024 | Flexitouch Plus, Entre Plus |
| Vifor Pharma, INC. | $13.83 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9.65 | 2019 | |
| Cardiovascular Systems INC. | $5.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhijeet Basoor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.